Recurrent Nasopharyngeal Carcinoma Clinical Trials in Nanning, Guangxi
3 recruitingNanning, Guangxi, China
Showing 1–3 of 3 trials
Recruiting
Phase 2
Camrelizumab and Chemotherapy Combined With Endoscopic Surgery for Recurrent Nasopharyngeal Carcinoma
Recurrent Nasopharyngeal Carcinoma
Eye & ENT Hospital of Fudan University100 enrolled7 locationsNCT05011227
Recruiting
Phase 2
Transnasal Endoscopic Surgery Combined With Adjuvant Immunotherapy for Recurrent NPC
Recurrent Nasopharyngeal Carcinoma
Eye & ENT Hospital of Fudan University77 enrolled8 locationsNCT05350891
Recruiting
Phase 3
Toripalimab for Local-regional Recurrent Nasopharyngeal Carcinoma
Recurrent Nasopharyngeal Carcinoma
Cancer Hospital of Guangxi Medical University204 enrolled1 locationNCT04376866